SLC25A25-AS1 overexpression was significantly relevant to the OS and PFI in PC patients with T2-3 stage, T3 stage, T3-4 stage, N0 stage, M0 stage, CR, R0, R1, PSA (<4 ng/ml), and GS. Here, SLC25A25 is linked to pachyonychia congenita.